Study finds that antireflux mucosectomy offers superior outcomes for GERD patients compared to antireflux mucosal ablation.
Study compared antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA) for GERD symptoms
ARMS showed better subjective and objective outcomes compared to ARMA
Patients who underwent ARMS had higher baseline GERDQ scores and greater postprocedure improvement
Significant improvement in reflux esophagitis with ARMS compared to ARMA
Both ARMS and ARMA are advantageous due to not requiring specialized equipment, being relatively inexpensive, and easily performed anywhere.
A study compared the effectiveness of antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA) in treating gastroesophageal reflux disease (GERD). The study included 274 patients, with ARMS showing better subjective and objective outcomes compared to ARMA. Patients who underwent ARMS had higher baseline scores on the GERD questionnaire and experienced greater post-procedure improvement in symptoms. ARMS also showed significant improvement in reflux esophagitis compared to ARMA, with similar improvements in Barrett esophagus. However, the ARMS group did experience higher rates of bleeding compared to the ARMA group.
The researchers noted that both ARMA and ARMS are beneficial treatment options for GERD as they do not require specialized equipment and are cost-effective. The study highlights the advantages of ARMS over ARMA in terms of symptom improvement and outcomes in patients with GERD. Further research and studies may be needed to better understand the long-term efficacy and safety of these procedures for managing GERD.
